Ten year breast cancer screening and follow up in 52200 women in Shahre-Kord, Iran (1997-2006)

R Khadivi--- Associated professor, Department of Community Medicine, Shahrekord University of Medical Sciences,
Iraj Harrirchi--- Associate Professor, Cancer Institue, Tehran University of Medical Sciences,
z Khosravi--- Health Center of Shahrekord District, Shahrekord University of Medical Sciences,
Mohammad Esmaeil Akbari--- Professor of surgical Oncology, Cancer Research Center, Shahid Beheshti Medical University (MC)

Abstract


377

Abstract:
Introduction: This study was conducted to determine the outcomes of the project of ‘Integration of Breast Cancer Screening and Early Detection’ into Primary Health Care (PHC) System and to detect the incidence rate, mortality rate and the stage of reported breast cancers, during the timeframe of the project in Shahre-Kord.
Method: A prospective cohort study was conducted, reviewing medical records of all women aged over 30 in Shahre-Kord district who participated in the screening project between 1997 and 2006. Patients’ demographic data, risk factors, diagnostic approach, treatments after definite diagnosis, and time of death of the deceased patients due to breast cancer were investigated from four sources: Provincial Health Centre, direct conversation via telephoning and interview, medical records of patients admitted to Seyed-Al Shohada Hospital, Isfahan (as the only referral oncology hospital in the region), and the provincial vital registry system as a part of national cancer registry.
Results: Overall 52200 women were eligible to enter the study and in this population, 40 breast cancer cases were detected. Incidence rate of breast cancer in women older than 30 years, during the timeframe of study, is estimated as 77.6 per 100000. Clinical features of the patients were as follow: stage-IIA (20%), stage-IIB (40%), stage-IIIA (30%) and stage-IIIB (10%). All 40 cases of cancer underwent pathology diagnosis, which showed infiltrative ductal carcinoma in 38%, invasive ductal carcinoma in 33%, ductal carcinoma in 25%, and infiltrative coloidal carcinoma in 4% of them. During the study, 31 cases (77.5%) survived and 9 cases (22.5%) died, all due to breast cancer.
Discussion and conclusion: The mean age of breast cancer in this study was significantly lower than Western countries. Mortality rate due to breast cancer in this study during ten year follow up was 1.73 in 100000 women population, which is less than the national figure of 3.16 in 100000.

Keywords: breast cancer, screening, mortality rate

Please cite this article as: Khadivi R, Harrirchi I, Khosravi Z, Akbari ME. Iran J Cancer Prev. 2008 ; 1(2):73-77.

References

1. Ursin G, Spicer DV, Bernstein L. Breast Cancer Epidemiology , Treatment and Prevention. Marlene B, Goldman, Maureen, and C.Hatch. Women and Health.  871­

883. 2000. Academic Press ,USA.

 

2. Louise A.Brinton. Cancer. Marlene B.Goldman and Maureen C. Hatch. Women and Health. 855. 2000. Academic Press ,USA.

 

3. Karla Kerlikowske. Breast cancer screening. Marlene B.Goldman and Maureen C.Hatch. Women and Health. 895-906. 2000. Academic Press ,USA. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, Chow LW, Masood S, Ramsey SD, Carlson RW: Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 12 Suppl 1:S3, 2006

 

4. Anderson BO, Braun S, Lim S, Smith RA, Taplin S, Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J 9 Suppl 2.2003:S51-S59, 

 

5. Anderson BO, Braun S, Lim S, Smith RA, Taplin S, Thomas DB: Early detection of breast cancer in countries with limited resources. Breast J 9 Suppl 2.2003:S51-S59,

 

6. De Koning HJ.Breast cancer screening; cost-effective in practice? Eur J Radiol.2000; 33(1):32

 

7. Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev.2006; 15(1):52

 

8. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006;15(1):45

 

9. Bland KI, Vezeridiz MP, Copeland III EM . Breast . In: Schwartz SI, Spencer FC, Daly JM, et al Principles Of Surgery , Vol 1 . Newyork , WB  Mc Graw - Hill . 1999 : 533-600. 2008.

 

10. Iranian Annual of National Cancer registration Report 2004, Islamic Republic of Iran, Ministry of Health and Medical Education, Health Deputy. 2006; Page 64-67

 

11. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z: Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev. 2006;7(4):571

 

12. Harirchi A, Zamani N, Samiei F. Evaluation and statistical analysis of project, Islamic Republic of Iran, Ministry of Health and Medical Education, Health Deputy, 1999, Page 8.

 

 

 

 

13. .Talei A.R , Sadeghi-Hasanabadi J, Saalabian  M,.. Arasteh M ,et al . A preliminary report on breast cancer screening program in Shiraz, southern Iran. Iranian Journal of Medical Sciences /Vol .22.No. 3&4.December 1999.146-148 . 2008.

 

14. Assadi K, Ovjee MR, Vahdat S, Shams S, Haghshenas M, Poursalimi Sh. Breast cancer screening in Bushehr port population aged 30-65 Yr. 3[1], 217-222. 1999. IRANIAN SOUTH MEDICAL JOURNAL

 

15. Boulos S, Gadallah M, Neguib S, Essam E, Youssef A, Costa A, Mittra I, Miller AB. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast . 2005;14(5):340,

 

16. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev.2004; 5(1):24

 

17. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A: Breast cancer in Iran: a review of 903 case records. Public Health. 2000; 114(2):143

 

18. Zafarghandi M, Harirchi A, Ebrahimi M, Zamani N et al Investigation of 3058 pathology report of breast diseases. Journal of Medical School, Tehran University of Medical Sciences, 1998, no 5, Page 47.

 

19. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Wang H, Lee J, Seow A, Lee HP: Do younger female breast

 

Ten year breast cancer screening and…

cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer . 2004;108(5):761

 

20. Taylor R, Davis P, Boyages J: Long-term survival of women with breast cancer in New South Wales. Eur J Cancer . 2003;39(2):215,

 

21. Vahdaninia M, Montazeri A: Breast cancer in Iran: a survival analysis. Asian Pac J Cancer Prev 5(2):223, 2004

 

22. Naghavi M. Mortality feature in 18 province of Iran, Islamic Republic of Iran, Ministry of Health and Medical Education, Health Deputy, 2002, Page 102.

 

23. Vargas HI, Anderson BO, Chopra R, Lehman CD, Ibarra JA, Masood S, Vass L: Diagnosis of breast cancer in countries with limited resources. Breast J 9 Suppl 2. 2003:S60-S66,

 

24. Rubin M, Horiuchi K, Joy N, Haun W, Read R, Ratzer E, Fenoglio M: Use of fine needle aspiration for solid breast lesions is accurate and cost-effective. Am J Surg . 1997;174(6):694

 

25. Jamali zavarei M, Sedigh N, Alizadeh Z, Montazeri A et al.Evaluation of breast aspiration in early diagnosis of breast cancer, Journal of Medical School, Tehran University of Medical Sciences, 1999, no 3, Page 17-21.

 


Full Text:

PDF

338